133 related articles for article (PubMed ID: 34263303)
1. Performance Evaluation of an Automated Fentanyl Immunoassay.
Tang MS; Lloyd M; Williams M; Farnsworth CW; Budelier MM
J Appl Lab Med; 2021 Sep; 6(5):1192-1201. PubMed ID: 34263303
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Two Commercially Available Fentanyl Screening Immunoassays for Clinical Use.
Budelier MM; Franks CE; Logsdon N; Jannetto PJ; Scott MG; Roper SM; Farnsworth CW
J Appl Lab Med; 2020 Nov; 5(6):1277-1286. PubMed ID: 32674121
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Analysis of Two Commonly Used FDA-Approved Immunoassays for Fentanyl Detection.
Lam KHB; Menlyadiev M; Buggs V; Parnprome S; Pesce A; Suhandynata RT; Fitzgerald RL; Song L; Metushi IG
J Appl Lab Med; 2024 Jun; ():. PubMed ID: 38831664
[TBL] [Abstract][Full Text] [Related]
4. Performance of Two Fentanyl Immunoassays against a Liquid Chromatography-Tandem Mass Spectrometry Method.
Feng S; Rutledge TJ; Manzoni M; Le T; Gardiner J; Milone M; Shaw L; Wang P
J Anal Toxicol; 2021 Feb; 45(2):117-123. PubMed ID: 32435812
[TBL] [Abstract][Full Text] [Related]
5. Performance of a Norfentanyl Immunoassay in Specimens with Low Concentrations of Fentanyl and/or Norfentanyl.
Uljon S; Tolan NV; Mahowald GK; Khaliq T; Urwiller ED; Fernandes MD; Basu SS; Kang P; Erickson TB; Hayes BD; Chai PR; Melanson SEF
J Appl Lab Med; 2024 Apr; ():. PubMed ID: 38656327
[TBL] [Abstract][Full Text] [Related]
6. Detection of 58 fentanyl analogs using ARK fentanyl II and Immunalysis fentanyl immunoassays.
Williams GR; Akala M; Wolf CE
Clin Biochem; 2023 Mar; 113():45-51. PubMed ID: 36610468
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the performance of the Roche FEN2 fentanyl immunoassay and its clinical implementation: The role of LDT-based mass spectrometry testing.
Menlyadiev M; Suhandynata RT; Lund K; Kelner MJ; Fitzgerald RL
J Mass Spectrom Adv Clin Lab; 2023 Apr; 28():105-113. PubMed ID: 37025609
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity of acetylfentanyl and risperidone with a fentanyl immunoassay.
Wang BT; Colby JM; Wu AH; Lynch KL
J Anal Toxicol; 2014; 38(9):672-5. PubMed ID: 25248490
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of xylazine among fentanyl screen-positive urines from hospitalized patients, Philadelphia, 2021.
Korn WR; Stone MD; Haviland KL; Toohey JM; Stickle DF
Clin Chim Acta; 2021 Oct; 521():151-154. PubMed ID: 34265257
[TBL] [Abstract][Full Text] [Related]
10. Advances in fentanyl testing.
Uljon S
Adv Clin Chem; 2023; 116():1-30. PubMed ID: 37852717
[TBL] [Abstract][Full Text] [Related]
11. Head to head evaluation of the analytical performance of two commercial methotrexate immunoassays and comparison with liquid chromatography-mass spectrometry and the former fluorescence polarization immunoassay.
Günther V; Mueller D; von Eckardstein A; Saleh L
Clin Chem Lab Med; 2016 May; 54(5):823-31. PubMed ID: 26457783
[TBL] [Abstract][Full Text] [Related]
12. Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry Assay for Quantifying Fentanyl and 22 Analogs and Metabolites in Whole Blood, Urine, and Hair.
Busardò FP; Carlier J; Giorgetti R; Tagliabracci A; Pacifici R; Gottardi M; Pichini S
Front Chem; 2019; 7():184. PubMed ID: 31001514
[TBL] [Abstract][Full Text] [Related]
13. Analysis, identification and confirmation of synthetic opioids using chloroformate chemistry: Retrospective detection of fentanyl and acetylfentanyl in urine and plasma samples by EI-GC-MS and HR-LC-MS.
Valdez CA; Leif RN; Corzett TH; Dreyer ML
PLoS One; 2022; 17(11):e0275931. PubMed ID: 36322521
[TBL] [Abstract][Full Text] [Related]
14. Development and Clinical Validation of a Sensitive Lateral Flow Assay for Rapid Urine Fentanyl Screening in the Emergency Department.
Li Z; Chen H; Feng S; Liu K; Wang P
Clin Chem; 2020 Feb; 66(2):324-332. PubMed ID: 32040576
[TBL] [Abstract][Full Text] [Related]
15. Performance of Fentanyl Immunoassays in an ED Patient Population.
Mills CM; Dryja PC; Champion-Lyons E; Keppler C; Babic N
J Appl Lab Med; 2024 Mar; ():. PubMed ID: 38517223
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the ARK Diagnostics immunoassay for qualitative detection of xylazine in urine.
Patrick BK; Christopher JM; Hua A; Joanne MT; Warren RK; Saldana-Reed A; Douglas FS
J Anal Toxicol; 2024 May; ():. PubMed ID: 38804901
[TBL] [Abstract][Full Text] [Related]
17. Improved Recognition of 25-Hydroxyvitamin D2 by 2 Automated Immunoassays.
Geno KA; Tolan NV; Singh RJ; Nerenz RD
J Appl Lab Med; 2020 Nov; 5(6):1287-1295. PubMed ID: 32529210
[TBL] [Abstract][Full Text] [Related]
18. A comparison between two different automated total 25-hydroxyvitamin D immunoassay methods using liquid chromatography-tandem mass spectrometry.
Kocak FE; Ozturk B; Isiklar OO; Genc O; Unlu A; Altuntas I
Biochem Med (Zagreb); 2015; 25(3):430-8. PubMed ID: 26526462
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the 25-hydroxy vitamin D assay on a fully automated liquid chromatography mass spectrometry system, the Thermo Scientific Cascadion SM Clinical Analyzer with the Cascadion 25-hydroxy vitamin D assay in a routine clinical laboratory.
Benton SC; Tetteh GK; Needham SJ; Mücke J; Sheppard L; Alderson S; Ruppen C; Curti M; Redondo M; Milan AM
Clin Chem Lab Med; 2020 Jun; 58(6):1010-1017. PubMed ID: 31851610
[TBL] [Abstract][Full Text] [Related]
20. Development of an UPLC-MS/MS method for the analysis of 16 synthetic opioids in segmented hair, and evaluation of the polydrug history in fentanyl analogue users.
Ramírez Fernández MDM; Wille SMR; Jankowski D; Hill V; Samyn N
Forensic Sci Int; 2020 Feb; 307():110137. PubMed ID: 31927248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
